BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹15 Cr | ₹31 Cr | ₹19 Cr | ₹19 Cr | ₹12 Cr |
What is the latest Net Current Assets ratio of BAL PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹19 Cr |
| Mar2021 | ₹12 Cr |
How is Net Current Assets of BAL PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹15 Cr | -50.58 | |
| Mar2024 | ₹31 Cr | 65.25 | |
| Mar2023 | ₹19 Cr | -0.55 | |
| Mar2022 | ₹19 Cr | 62.96 | |
| Mar2021 | ₹12 Cr | - | |
Compare Net Current Assets of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹127.3 Cr | -3.8% | -1.3% | -19.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,195.0 Cr | 3.2% | 12.4% | 11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,993.0 Cr | 1.8% | 11% | 10.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,926.0 Cr | 3.8% | 6.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹113,052.0 Cr | 6.2% | 13.9% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,333.0 Cr | 5.4% | 8% | 9.1% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -3.8% |
-1.3% |
-19.4% |
| SENSEX | 1% |
-4.1% |
-7.4% |
You may also like the below Video Courses